{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T07:45:20Z","timestamp":1770882320765,"version":"3.50.1"},"reference-count":11,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2000,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Timely diagnosis of leptospirosis is important to ensure a favorable clinical outcome. The definitive serologic assay, the microscopic agglutination test (MAT), requires paired sera and is not useful for guiding early clinical management. The only screening test approved for use in the United States, the indirect hemagglutination assay (IHA), has not undergone extensive field evaluation. To assess the performance of the leptospirosis IHA in Hawaii, serum from patients evaluated for leptospirosis between 1992 and 1997 were tested with the IHA at the Hawaii State Laboratories Division and with the MAT at the Centers for Disease Control and Prevention. Leptospirosis was considered confirmed by a fourfold rise in MAT titer and\/or a positive culture. A total of 92 (41%) of 226 specimens from 114 persons with confirmed leptospirosis were found positive by IHA. Only 18 (15%) of 119 specimens obtained within 14 days of onset were IHA positive, compared to 74 (69%) of 107 specimens collected more than 14 days after onset (\n            <jats:italic>P<\/jats:italic>\n            &lt;0.001). Repeat testing ultimately resulted in 78 (68%) of the confirmed cases having at least one specimen found positive by IHA. Thirteen different presumptive infecting serogroups were identified among 251 specimens with an MAT titer of \u2265200 and obtained from persons with confirmed or probable leptospirosis. Fifty (68%) of 73 specimens with Icterohaemorrhagiae as the presumptive infecting serogroup were found positive by IHA, compared to 44 (47%) of 93 specimens with Australis as the presumptive infecting serogroup (\n            <jats:italic>P<\/jats:italic>\n            , 0.01). The IHA test was positive for 3 (1%) of 236 specimens from 154 persons without leptospirosis. The sensitivity of the leptospirosis IHA in Hawaii was substantially below figures reported previously, particularly early in the course of illness, limiting its usefulness for diagnosing acute infection. Since the presumptive infecting serogroup affected IHA results and the prevalence of serovars varies with geography, the performance of the IHA should be assessed locally. More sensitive leptospirosis screening tests are needed in Hawaii.\n          <\/jats:p>","DOI":"10.1128\/jcm.38.3.1081-1084.2000","type":"journal-article","created":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T17:53:55Z","timestamp":1577814835000},"page":"1081-1084","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":33,"title":["Evaluation of the Indirect Hemagglutination Assay for Diagnosis of Acute Leptospirosis in Hawaii"],"prefix":"10.1128","volume":"38","author":[{"given":"Paul V.","family":"Effler","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Epidemiology Branch, Communicable Disease Division, Hawaii State Department of Health, Honolulu, Hawaii 968131;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry Y.","family":"Domen","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Medical Microbiology Branch, State Laboratories Division, Hawaii State Department of Health, Pearl City, Hawaii 967822; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra L.","family":"Bragg","sequence":"additional","affiliation":[{"name":"<!--label omitted: 3-->CDC\/WHO Collaborating Center for Leptospirosis, Meningitis and Special Pathogens Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 303333"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tin","family":"Aye","sequence":"additional","affiliation":[{"name":"<!--label omitted: 3-->CDC\/WHO Collaborating Center for Leptospirosis, Meningitis and Special Pathogens Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 303333"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Sasaki","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Epidemiology Branch, Communicable Disease Division, Hawaii State Department of Health, Honolulu, Hawaii 968131;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","unstructured":"Benenson\nA. S.\nControl of communicable diseases manual\n16th ed.\n1995\nAmerican Public Health Association\nWashington D.C."},{"key":"e_1_3_2_3_2","first-page":"49","article-title":"Case definitions for infectious conditions under public health surveillance","volume":"46","author":"Centers for Disease Control and Prevention","year":"1997","unstructured":"Centers for Disease Control and Prevention Case definitions for infectious conditions under public health surveillance.Morbid. Mortal. Weekly Rep.46199749","journal-title":"Morbid. Mortal. Weekly Rep."},{"key":"e_1_3_2_4_2","first-page":"74","article-title":"Summary of notifiable diseases, United States","volume":"45","author":"Centers for Disease Control and Prevention","year":"1996","unstructured":"Centers for Disease Control and Prevention Summary of notifiable diseases, United States.Morbid. Mortal. Weekly Rep.45199674","journal-title":"Morbid. Mortal. Weekly Rep."},{"key":"e_1_3_2_5_2","first-page":"673","article-title":"Update: leptospirosis and unexplained acute febrile illness among athletes participating in triathlons\u2014Illinois and Wisconsin, 1998","volume":"47","author":"Centers for Disease Control and Prevention","year":"1998","unstructured":"Centers for Disease Control and Prevention Update: leptospirosis and unexplained acute febrile illness among athletes participating in triathlons\u2014Illinois and Wisconsin, 1998.Morbid. Mortal. Weekly Rep.471998673676","journal-title":"Morbid. Mortal. Weekly Rep."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/am.25.6.976-980.1973"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1080\/00034983.1990.11812465"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.36.1.11-14.1998"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1993.48.35"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(99)90293-6"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.2.3.218-221.1975"},{"key":"e_1_3_2_12_2","unstructured":"Weyant\nR. S.\nBragg\nS. L.\nKaufmann\nA. F.\nLeptospira and Leptonema\nManual of clinical microbiology\n7th ed.\nMurray\nP. R.\nBaron\nE. J.\nPfaller\nM. A.\nTenover\nF. C.\nYolken\nR. H.\n1999\n739\n745\nAmerican Society for Microbiology\nWashington D.C."}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.38.3.1081-1084.2000","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.38.3.1081-1084.2000","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T00:25:31Z","timestamp":1646439931000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.38.3.1081-1084.2000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,3]]}},"alternative-id":["10.1128\/JCM.38.3.1081-1084.2000"],"URL":"https:\/\/doi.org\/10.1128\/jcm.38.3.1081-1084.2000","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,3]]},"assertion":[{"value":"1999-10-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1999-12-20","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2000-03-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}